Here are five observations:
1. Market drivers include an aging population and decreasing hospital costs due to shorter length of stay.
2. Robot-guided spine surgery is intended to be less invasive, with less blood loss and faster recovery.
3. In 2015, 78 million people experienced chronic back pain worldwide, with 11 million in the United States.
4. Mazor Robotics dominates the spinal surgical robot market, with a measureable market share.
5. Accel Spine, Alliance Spine, Alphatec Spine, Apollo Spine, Ascendx Spine and Back 2 Basics Spine also lead the space.
More articles on devices:
Stryker, Zimmer Biomet, NuVasive & more: 12 key notes
Implanet’s spine activity jumps 38% in 1st half of 2016 — 8 report highlights
Zimmer Biomet pledges $100k to OREF for orthopedic research: 5 key notes
